| 发明名称 | Putrescine and method to reduce risk of aneuploid pregnancy | ||
| 摘要 | A medicament for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ornithine decarboxylase (ODC) activity level, the medicament includes putrescine. A use of putrescine for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels. A method for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels by administering putrescine. | ||
| 申请公布号 | US9248108(B2) | 申请公布日期 | 2016.02.02 |
| 申请号 | US201314422598 | 申请日期 | 2013.08.21 |
| 申请人 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 发明人 | Liu Xingquan Johné;Tao Yong |
| 分类号 | A61K31/132 | 主分类号 | A61K31/132 |
| 代理机构 | Borden Ladner Gervais LLP | 代理人 | Nauman David;Borden Ladner Gervais LLP |
| 主权项 | 1. A method of reducing the risk of having an aneuploid pregnancy in a human female with reduced ovarian ornithine decarboxylase (ODC) activity level, the method comprising: administering putrescine to a peri-ovulatory human female. | ||
| 地址 | Ottawa CA | ||